Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cohn

Showing results (431-440 of 612) with videos related to

Pageof 62
Sort By:
Medical and Pediatric Oncology|December 7, 2000
Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastomaX X Tang, H Zhao, M E Robinson, et al.
Cancer Letters|July 19, 2005
The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectivesWendy B London, Luca Boni, Thorsten Simon, et al.
Clinical & Experimental Metastasis|March 1, 1997
Modulation of N-myc expression alters the invasiveness of neuroblastomaL A Goodman, B C Liu, C J Thiele, et al.
Journal of Clinical Microbiology|May 1, 1991
Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in human immunodeficiency virus-positive and -negative individualsB Y Lee, D Chatterjee, C M Bozic, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 2, 2014
Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin(®) Registry - Investigation of Effectiveness and Safety (ARIES) observational cohort studyH I Hurwitz, T S Bekaii-Saab, J C Bendell, et al.
Lancet (London, England)|February 9, 1991
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma ScreeningS B Murphy, S L Cohn, A W Craft, et al.
Annals of Internal Medicine|September 15, 1994
Megestrol acetate in patients with AIDS-related cachexiaJ H Von Roenn, D Armstrong, D P Kotler, et al.
Cancer Research|May 1, 1986
Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndromeE Borek, O K Sharma, F L Buschman, et al.
Clinical Colorectal Cancer|August 23, 2011
An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancerAllen L Cohn, Grace C Shumaker, Pankaj Khandelwal, et al.
Cancer Research Communications|August 5, 2024
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic SignaturesMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Pageof 62

Showing results (431-440 of 612) with videos related to

Sort By:
Pageof 62
Medical and Pediatric Oncology|December 7, 2000
Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastomaX X Tang, H Zhao, M E Robinson, et al.
Cancer Letters|July 19, 2005
The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectivesWendy B London, Luca Boni, Thorsten Simon, et al.
Clinical & Experimental Metastasis|March 1, 1997
Modulation of N-myc expression alters the invasiveness of neuroblastomaL A Goodman, B C Liu, C J Thiele, et al.
Journal of Clinical Microbiology|May 1, 1991
Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in human immunodeficiency virus-positive and -negative individualsB Y Lee, D Chatterjee, C M Bozic, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 2, 2014
Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin(®) Registry - Investigation of Effectiveness and Safety (ARIES) observational cohort studyH I Hurwitz, T S Bekaii-Saab, J C Bendell, et al.
Lancet (London, England)|February 9, 1991
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma ScreeningS B Murphy, S L Cohn, A W Craft, et al.
Annals of Internal Medicine|September 15, 1994
Megestrol acetate in patients with AIDS-related cachexiaJ H Von Roenn, D Armstrong, D P Kotler, et al.
Cancer Research|May 1, 1986
Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndromeE Borek, O K Sharma, F L Buschman, et al.
Clinical Colorectal Cancer|August 23, 2011
An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancerAllen L Cohn, Grace C Shumaker, Pankaj Khandelwal, et al.
Cancer Research Communications|August 5, 2024
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic SignaturesMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.
Pageof 62